Neurotoxic Effects of Electronic Cigarette Exposure on the Central Nervous System: A Scoping Review
Öz
Electronic cigarettes (e-cigarettes) have achieved global adoption, with an estimated 82 million users worldwide and disproportionate uptake among adolescents. Despite marketing as a safer tobacco alternative, e-cigarette aerosols contain neurotoxic constituents including nicotine, flavoring agents, carbonyl compounds, and heavy metals. This review maps empirical evidence on CNS effects of e-cigarette exposure across biological model types. A systematic scoping review was conducted per the Arksey and O'Malley framework and reported per PRISMA-ScR guidelines. PubMed and Scopus were searched in January 2026 for studies from 2015 to 2026 examining quantifiable CNS outcomes following e-cigarette exposure in human, animal, or in vitro models. Data were extracted across eight domains and synthesized narratively. Seventy-four studies met inclusion criteria: 49 animal in vivo (66.2%), 17 human (23.0%), and 8 in vitro (10.8%), spanning 14 countries. Seven CNS outcome domains were identified: neuroinflammation and oxidative stress, blood-brain barrier (BBB) integrity, cognitive and behavioral outcomes, neuroimaging and pharmacokinetics, neurotransmitter systems and electrophysiology, developmental neurotoxicology, and other outcomes. Neuroinflammation and BBB disruption showed high directional consistency. Cognitive impairment, hippocampal volume reductions, and reward circuit reorganization were consistently observed. Developmental studies identified epigenomic reprogramming and disrupted GABAergic interneuron migration. Non-nicotine constituents were independently implicated in CNS toxicity. E-cigarette exposure is associated with a consistent and biologically plausible pattern of CNS harm. The developing brain represents a priority risk population given its heightened vulnerability to neurotoxic insult. Current evidence does not support the neurological safety of e-cigarettes; regulatory frameworks should mandate rigorous CNS-specific toxicity assessment for electronic nicotine delivery systems.
Anahtar Kelimeler
Destekleyen Kurum
Etik Beyan
Teşekkür
Kaynakça
- 1. Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: Review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction. 2014;109(11):1801-1810. doi:10.1111/add.12659
- 2. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139. doi:10.1136/tobaccocontrol-2012-050859
- 3. Hartmann-Boyce J, McRobbie H, Butler AR, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2021;9(9):CD010216. doi:10.1002/14651858.CD010216.pub6
- 4. Jerzyński T, Stimson GV. Estimation of the global number of vapers: 82 million worldwide in 2021. Drugs Habits Soc Policy. 2023;24(2):91-3. doi:10.1108/DHS-07-2022-0028
- 5. Gentzke AS, Wang TW, Cornelius M, et al. Tobacco product use and associated factors among middle and high school students-National Youth Tobacco Survey, United States, 2021. MMWR Surveill Summ. 2022;71(5):1-29. doi:10.15585/mmwr.ss7105a1
- 6. World Health Organization. Tobacco: E-cigarettes [Fact sheet]. 2023. https://www.who.int/news-room/fact-sheets/detail/tobacco
- 7. Gravely S, Craig LV, Commar A, Schotte K, Fong GT. Estimating the global number of e-cigarette users in 2020. Harm Reduct J. 2021;18:109. doi:10.1186/s12954-021-00556-7
- 8. World Health Organization. WHO global report on trends in prevalence of tobacco use 2000-2025 and projections to 2030. Geneva: WHO; 2025.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Hücresel Sinir Sistemi, Merkezi Sinir Sistemi
Bölüm
Derleme
Yazarlar
Yayımlanma Tarihi
31 Ağustos 2026
Gönderilme Tarihi
21 Mart 2026
Kabul Tarihi
14 Ağustos 2026
Yayımlandığı Sayı
Yıl 2026 Cilt: 13 Sayı: 2